Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1263
| Despition | MAPK7 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1135 | ACTH Blocking Peptide (AC1135) | 250 µg | inquiry |
| ACPP-1001 | Recombinant Human DEGA Protein (6×His Tag) (AC1001) | 50 µg | inquiry |
| ACPP-1071 | Visfatin Blocking Peptide (AC1071) | 250 µg | inquiry |
| ACPP-1353 | PDE7B Blocking Peptide (AC1353) | 250 µg | inquiry |
| ACPP-1278 | EAAT1 Blocking Peptide (AC1278) | 250 µg | inquiry |
| ACPP-1291 | FGFR1 Blocking Peptide (AC1291) | 250 µg | inquiry |
| ACPP-1716 | Mouse ANGPTL7 Protein (AC1716) | 1 µg | inquiry |
| ACPP-1554 | Human Human FGF1 (Active) Protein (AC1554) | 500U | inquiry |
| ACPP-1502 | Human DAG1 Protein (AC1502) | 2 µg | inquiry |
| ACPP-1115 | Recombinant Human CD45 Protein (6×His Tag) (AC1115) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.